Immunity to Cas9 as an Obstacle to Persistent Genome Editing.
Molecular therapy : the journal of the American Society of Gene Therapy, 28(6): 1389-1391 PMID 32428441 DOI 10.1016/j.ymthe.2020.05.007
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.